These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34778950)

  • 1. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
    Miceli F; Guerrini R; Nappi M; Soldovieri MV; Cellini E; Gurnett CA; Parmeggiani L; Mei D; Taglialatela M
    Epilepsia; 2022 Jan; 63(1):e7-e14. PubMed ID: 34778950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
    Dinoi G; Morin M; Conte E; Mor Shaked H; Coppola MA; D'Adamo MC; Elpeleg O; Liantonio A; Hartmann I; De Luca A; Blunck R; Russo A; Imbrici P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
    Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
    Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.
    Rogers A; Golumbek P; Cellini E; Doccini V; Guerrini R; Wallgren-Pettersson C; Thuresson AC; Gurnett CA
    Am J Med Genet A; 2018 Aug; 176(8):1748-1752. PubMed ID: 30055040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.
    Verdura E; Fons C; Schlüter A; Ruiz M; Fourcade S; Casasnovas C; Castellano A; Pujol A
    J Med Genet; 2020 Feb; 57(2):132-137. PubMed ID: 31586945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNA1 gain-of-function epileptic encephalopathy treated with 4-aminopyridine.
    Müller P; Takacs DS; Hedrich UBS; Coorg R; Masters L; Glinton KE; Dai H; Cokley JA; Riviello JJ; Lerche H; Cooper EC
    Ann Clin Transl Neurol; 2023 Apr; 10(4):656-663. PubMed ID: 36793218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
    Ishida S; Sakamoto Y; Nishio T; Baulac S; Kuwamura M; Ohno Y; Takizawa A; Kaneko S; Serikawa T; Mashimo T
    Brain Res; 2012 Jan; 1435():154-66. PubMed ID: 22206926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Spectrum of
    Paulhus K; Ammerman L; Glasscock E
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Genetic Variants Expand the Functional, Molecular, and Pathological Diversity of
    Paulhus K; Glasscock E
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.
    Tristán-Clavijo E; Scholl FG; Macaya A; Iglesias G; Rojas AM; Lucas M; Castellano A; Martinez-Mir A
    Mov Disord; 2016 Nov; 31(11):1743-1748. PubMed ID: 27477325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalopathy related to status epilepticus during sleep due to a de novo KCNA1 variant in the Kv-specific Pro-Val-Pro motif: phenotypic description and remarkable electroclinical response to ACTH.
    Russo A; Gobbi G; Pini A; Møller RS; Rubboli G
    Epileptic Disord; 2020 Dec; 22(6):802-806. PubMed ID: 33355533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel
    Imbrici P; Conte E; Blunck R; Stregapede F; Liantonio A; Tosi M; D'Adamo MC; De Luca A; Brankovic V; Zanni G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
    Manville RW; Abbott GW
    J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
    Masnada S; Hedrich UBS; Gardella E; Schubert J; Kaiwar C; Klee EW; Lanpher BC; Gavrilova RH; Synofzik M; Bast T; Gorman K; King MD; Allen NM; Conroy J; Ben Zeev B; Tzadok M; Korff C; Dubois F; Ramsey K; Narayanan V; Serratosa JM; Giraldez BG; Helbig I; Marsh E; O'Brien M; Bergqvist CA; Binelli A; Porter B; Zaeyen E; Horovitz DD; Wolff M; Marjanovic D; Caglayan HS; Arslan M; Pena SDJ; Sisodiya SM; Balestrini S; Syrbe S; Veggiotti P; Lemke JR; Møller RS; Lerche H; Rubboli G
    Brain; 2017 Sep; 140(9):2337-2354. PubMed ID: 29050392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
    Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kcna1a mutant zebrafish model episodic ataxia type 1 (EA1) with epilepsy and show response to first-line therapy carbamazepine.
    Dogra D; Meza-Santoscoy PL; Gavrilovici C; Rehak R; de la Hoz CLR; Ibhazehiebo K; Rho JM; Kurrasch DM
    Epilepsia; 2023 Aug; 64(8):2186-2199. PubMed ID: 37209379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.
    van der Wijst J; Konrad M; Verkaart SAJ; Tkaczyk M; Latta F; Altmüller J; Thiele H; Beck B; Schlingmann KP; de Baaij JHF
    Nephron; 2018; 139(4):359-366. PubMed ID: 29791908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.1 channel subunits in the control of neurocardiac function.
    Glasscock E
    Channels (Austin); 2019 Dec; 13(1):299-307. PubMed ID: 31250689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel KCNA1 mutation causing episodic ataxia type I.
    Lassche S; Lainez S; Bloem BR; van de Warrenburg BP; Hofmeijer J; Lemmink HH; Hoenderop JG; Bindels RJ; Drost G
    Muscle Nerve; 2014 Aug; 50(2):289-91. PubMed ID: 24639406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.